Skip to main content

Controversial New Alzheimer's Drug: What to Know

By
aducanumab

As the first Alzheimer's drug approved since 2003, advocates applaud the decision. Critics say the approval was based on inadequate proof that the drug works and balk at the price tag of $56,000 a year.



from WebMD Health https://ift.tt/3iyW0GD
via IFTTT
Labels:

Comments

Post a Comment

Popular posts from this blog

Vitiligo: Treatment Options and Innovations

By
Vitiligo causes white patches on your skin that can affect your quality of life and even be emotionally devastating. Treatments include tried-and-true steroid creams, new immune-suppressing drugs, light therapy, and cell transplant surgery. from WebMD Health https://ift.tt/QBepsRw via IFTTT
Post a Comment
Read more

The Future of Autoimmune Disorders: Psoriatic Disease

By
What's being done to help people with psoriatic disease? We get a look at the ever-changing picture from a rheumatologist. from WebMD Health https://ift.tt/5P6ZHyd via IFTTT
Post a Comment
Read more

Study: Black Men Twice as Likely to Develop Prostate Cancer as Whites

By
A review of men seen at VA hospitals found that Black veterans had nearly twice the incidence of localized and advanced prostate cancer as white men. from WebMD Health https://ift.tt/3Knscs2 via IFTTT
Post a Comment
Read more